Decreased tumorigenicity in vivo when transforming growth factor beta treatment causes cancer cell senescence

Yoshinori Katakura1, Eriko Nakata, Yukiko Tabira

  • 1Department of Genetic Resources Technology, Faculty of Agriculture, Kyushu University, Fukuoka 812-8581, Japan. katakura@grt.kyushu-u.ac.jp

Insights

Forced senescence in A549 lung adenocarcinoma cells suppressed tumor formation. This study shows inducing senescence may be a new anti-cancer therapy strategy.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Molecular Biology

Background:

  • Transforming growth factor beta (TGF-beta) induces two senescence pathways in A549 lung adenocarcinoma cells: replicative and premature.
  • Senescence is a cellular state of irreversible growth arrest.

Purpose of the Study:

  • To investigate if forced senescence can suppress cancer cell tumor phenotypes.
  • To evaluate the tumorigenicity of senescent A549 cells.

Main Methods:

  • A549 human lung adenocarcinoma cells were treated with TGF-beta for over 50 days to induce senescence.
  • Senescence was induced via telomere shortening-dependent or independent pathways.
  • Senescent cells were analyzed for morphology, contact inhibition, cytokine secretion (IL-6), and tumorigenicity in nude mice.

Main Results:

  • Long-term TGF-beta treatment induced senescence in A549 cells.
  • Senescent A549 cells exhibited altered morphology, contact inhibition, and secreted IL-6.
  • Crucially, senescent A549 cells demonstrated a complete lack of tumorigenicity in vivo.

Conclusions:

  • Forced induction of senescence effectively suppresses the tumor-forming capabilities of cancer cells.
  • Targeting senescence pathways presents a promising novel strategy for developing advanced anti-cancer therapies.

Related Concept Videos

Decreasing Function01:27

Decreasing Function

A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2​ in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
303
Factors Influencing Microbial Growth: pH01:29

Factors Influencing Microbial Growth: pH

Microorganisms are classified as acidophiles, neutrophiles, or alkaliphiles based on their pH growth preferences, reflecting their adaptations to specific environments. Maintaining a stable intracellular pH is critical for macromolecular stability and enzymatic activity, which can be challenged by external pH variations.Neutrophiles, such as Escherichia coli, grow optimally between pH 5.5 and 8.0. These microorganisms inhabit neutral or slightly acidic environments and employ mechanisms like...
1.2K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.4K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
60.1K